01626nam a2200373 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020003000112020002700142020002700169040002100196035002100217050002300238082001600261100002800277245011900305260006500424300002900489490005700518504005100575505010500626533015200731650002700883650005200910655002900962700003300991710001701024830006601041856012601107999001901233ebr10674883CaPaEBRm        u        cr cn|||||||||100122s2010    nyuab   sb    001 0 eng d  z  2010002978  z9781616682330 (softcover)  z1616682337 (softcover)  z9781616684785 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)68262115714aRM409b.V56 2010eb04a615.5/82221 aVin�sov�a, Jarmila.10aDevelopment of new MDR-tuberculosis drugsh[electronic resource] /cJarmila Vin�sov�a and Martin Kr�atk�y.  aNew York :bNova Science Publishers/Nova Biomedical,cc2010.  axii, 98 p. :bill., map.1 aPharmacology-research, safety testing and regulation  aIncludes bibliographical references and index.0 aResistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntitubercular agents. 0aMultidrug-resistant tuberculosisxChemotherapy. 7aElectronic books.2local1 aKr�atk�y, Martin,d1960-2 aebrary, Inc. 0aPharmacology-research, safety testing, and regulation series.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10674883zAn electronic book accessible through the World Wide Web; click to view  c163758d163758